{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Indacaterol+maleate", "query": { "intervention": "Indacaterol maleate" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 9, "total_pages": 1, "next_page_url": null, "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-29T14:15:39.165Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03257995", "title": "Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Indacaterol maleate", "type": "DRUG" }, { "name": "Indacaterol acetate", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 54, "start_date": "2017-09-05", "completion_date": "2018-01-18", "has_results": true, "last_update_posted_date": "2021-01-05", "last_synced_at": "2026-09-29T14:15:39.165Z", "location_count": 6, "location_summary": "North Dartmouth, Massachusetts • St Louis, Missouri • Skillman, New Jersey + 3 more", "locations": [ { "city": "North Dartmouth", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Skillman", "state": "New Jersey" }, { "city": "Raleigh", "state": "North Carolina" }, { "city": "Medford", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT03257995" }, { "nct_id": "NCT01156844", "title": "Efficacy, Safety and Pharmacokinetics of Different Regimens of Indacaterol", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Persistent Asthma" ], "interventions": [ { "name": "Indacaterol", "type": "DRUG" }, { "name": "Placebo to Indacaterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 191, "start_date": "2010-03", "completion_date": null, "has_results": true, "last_update_posted_date": "2011-08-17", "last_synced_at": "2026-09-29T14:15:39.165Z", "location_count": 21, "location_summary": "Anniston, Alabama • Cypress, California • Fresno, California + 16 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Cypress", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01156844" }, { "nct_id": "NCT02487446", "title": "Efficacy and Safety Study of QVA149 in COPD Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "QVA149", "type": "DRUG" }, { "name": "Umeclidinium/vilanterol", "type": "DRUG" }, { "name": "Placebo (umeclidinium/vilanterol)", "type": "DRUG" }, { "name": "Placebo (QVA149)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 357, "start_date": "2015-07-28", "completion_date": "2016-09-12", "has_results": true, "last_update_posted_date": "2017-12-26", "last_synced_at": "2026-09-29T14:15:39.165Z", "location_count": 58, "location_summary": "Andalusia, Alabama • Anniston, Alabama • Jasper, Alabama + 52 more", "locations": [ { "city": "Andalusia", "state": "Alabama" }, { "city": "Anniston", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" }, { "city": "Multiple Locations", "state": "Alabama" }, { "city": "Multiple Locations", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02487446" }, { "nct_id": "NCT00941798", "title": "Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "QMF149 Twisthaler®", "type": "DRUG" }, { "name": "Mometasone Twisthaler®", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "12 Years to 70 Years" }, "enrollment_count": 2283, "start_date": "2009-07", "completion_date": "2011-05", "has_results": true, "last_update_posted_date": "2012-08-31", "last_synced_at": "2026-09-29T14:15:39.165Z", "location_count": 92, "location_summary": "Birmingham, Alabama • Buena Park, California • Encinitas, California + 80 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Buena Park", "state": "California" }, { "city": "Encinitas", "state": "California" }, { "city": "Fullerton", "state": "California" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00941798" }, { "nct_id": "NCT01682863", "title": "A Multi-centre Randomized Double Blind 52-week Study to Assess the Safety of QVA149 Compared to QAB149 in Patients With COPD Who Have Moderate to Severe Airflow Limitation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease (COPD)" ], "interventions": [ { "name": "QVA149", "type": "DRUG" }, { "name": "QAB149", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 614, "start_date": "2012-10", "completion_date": "2014-06", "has_results": true, "last_update_posted_date": "2016-03-30", "last_synced_at": "2026-09-29T14:15:39.165Z", "location_count": 47, "location_summary": "Vestavia Hills, Alabama • Huntington Beach, California • Lakewood, California + 43 more", "locations": [ { "city": "Vestavia Hills", "state": "Alabama" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Lakewood", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01682863" }, { "nct_id": "NCT00403637", "title": "Efficacy and Safety of Single Doses of Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) Compared to Placebo in Patients With Persistent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "indacaterol maleate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "12 Years to 75 Years" }, "enrollment_count": 45, "start_date": "2006-11", "completion_date": "2007-02", "has_results": false, "last_update_posted_date": "2016-11-18", "last_synced_at": "2026-09-29T14:15:39.165Z", "location_count": 5, "location_summary": "Denver, Colorado • North Dartmouth, Massachusetts • Minneapolis, Minnesota + 2 more", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "North Dartmouth", "state": "Massachusetts" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Raleigh", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00403637" }, { "nct_id": "NCT02487498", "title": "Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "QVA149", "type": "DRUG" }, { "name": "Umeclidinium/vilanterol", "type": "DRUG" }, { "name": "Placebo (umeclidinium/vilanterol )", "type": "DRUG" }, { "name": "Placebo (QVA149)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 355, "start_date": "2015-07-27", "completion_date": "2016-09-06", "has_results": true, "last_update_posted_date": "2018-04-02", "last_synced_at": "2026-09-29T14:15:39.165Z", "location_count": 53, "location_summary": "Anaheim, California • Escondido, California • Riverside, California + 45 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Escondido", "state": "California" }, { "city": "Riverside", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02487498" }, { "nct_id": "NCT01712516", "title": "A 12-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease (COPD)" ], "interventions": [ { "name": "QVA149", "type": "DRUG" }, { "name": "QAB149", "type": "DRUG" }, { "name": "NVA237", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 1001, "start_date": "2012-12", "completion_date": "2014-02", "has_results": true, "last_update_posted_date": "2015-07-15", "last_synced_at": "2026-09-29T14:15:39.165Z", "location_count": 56, "location_summary": "Huntsville, Alabama • *See Various Dept.'s*, Arizona • Tempe, Arizona + 46 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "*See Various Dept.'s*", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Buena Park", "state": "California" }, { "city": "Fullerton", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01712516" }, { "nct_id": "NCT01727141", "title": "A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease (COPD)" ], "interventions": [ { "name": "QVA149", "type": "DRUG" }, { "name": "QAB149", "type": "DRUG" }, { "name": "NVA237", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 1042, "start_date": "2012-11", "completion_date": "2014-02", "has_results": true, "last_update_posted_date": "2016-03-29", "last_synced_at": "2026-09-29T14:15:39.165Z", "location_count": 73, "location_summary": "Birmingham, Alabama • Montgomery, Alabama • Mesa, Arizona + 60 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Fountain Valley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01727141" } ] }